ACADIA PHARMACEUTICALS INC. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
ACADIA PHARMACEUTICALS INC. (ACAD) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2016-02-29
- ACADIA PHARMACEUTICALS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2015 was $0.00.
- ACADIA PHARMACEUTICALS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2014 was $0.00.
- ACADIA PHARMACEUTICALS INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2013 was $0.00.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |